HORMAD1 and cancer: Whilst we found that HORMAD1 expression leads to impaired RAD51-dependent homologous recombination in isogenic murine embryonic stem cells and in breast cancer models, others have suggested that HORMAD1 expression enhances homologous recombination in models of other genomically unstable cancer types, such as lung adenocarcinomas [17, 18].